Oral H1 Antihistamines (2nd Generation)
Treatment for Allergic Rhinitis
Typical Dosage: 10mg once daily (e.g., Cetirizine, Loratadine)
Effectiveness
75%
Safety Score
82%
Clinical Trials
1
Participants
80K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
82
DangerousModerateSafe
Treatment Details
Dosage Range
10mg once daily (e.g., Cetirizine, Loratadine)
Time to Effect
30-60 minutes
Treatment Duration
Seasonal or daily as needed
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$600
Side Effect Mgmt:$5
Total Annual:$755
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.03
Outcome-Based Costs
Cost per Responder
$227.94
Cost per Remission
$1,033.33
Oral H1 Antihistamines (2nd Generation) Outcomes
for Allergic Rhinitis
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+68%
Remission Rate
+15%
Common Side Effects
Drowsiness
+7%
Dry mouth
+3%
Headache
+7%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov